MedTrace Logo

Toronto Gestational Glucose Tolerance Cohort

NCT02583061 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2025-05-09

No results posted yet for this study

Summary

In this prospective observational cohort study, women representing the full spectrum of gestational glucose tolerance status are undergoing longitudinal cardiometabolic characterization at regular intervals in the years after the index pregnancy.

Conditions

  • Type 2 Diabetes, Gestational Diabetes, Pre-diabetes

Interventions

OTHER

There is no intervention. An exposure of interest is glucose tolerance status in pregnancy

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Mount Sinai Hospital, Canada

    lead OTHER

Principal Investigators

  • Ravi Retnakaran, MD · MOUNT SINAI HOSPITAL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2029-10-31
Completion
2029-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02583061 on ClinicalTrials.gov